Cargando…
抗CD19 CAR-T细胞序贯异基因造血干细胞移植术治疗难治B淋巴细胞白血病疗效及安全性观察
OBJECTIVE: To investigate the efficacy and side effects of anti-CD19 CAR-T cell bridging to allogeneic hematopoietic stem cell transplantation （allo-HSCT） regimen for refractory Blymphoblastic leukemia. METHODS: 10 patients with refractory B-lymphoblastic leukemia with minimal residual disease（MRD）n...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357920/ https://www.ncbi.nlm.nih.gov/pubmed/32311895 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.03.010 |